BTA
Click for more information
0.00% 57.0¢ biota holdings limited

http://www.medcitynews.com/2011/01/flu-treatment-developer-seeks-...

  1. simonj
    1,833 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    14/01/11
    17:50
    Post #: 7738086

    http://www.medcitynews.com/2011/01/flu-treatment-developer-seeks-revisions-for-phase-iii-study/

    "Drug developer BioCryst Pharmaceuticals needs more money and more time to complete a phase III clinical trial of its flu treatment peramivir, the company disclosed Thursday..."

    Moving the goalposts to get the desired outcome..?
    BTA Price at posting: $1.28 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade niobium extended across multiple targets
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
NEWS Gold resource at Minyari Dome grows by 33% – discover the multi-metal potential
right-arrow Created with Sketch.
NEWS RDN: HotCopper's most discussed stock
right-arrow Created with Sketch.
NEWS HotCopper users bullish on Raiden's news it won Andover South approval as expected
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.